Life-Saving pill tested to shield children from devastating strokes
NCT ID NCT06526117
Summary
This study aims to prevent first strokes in children with sickle cell disease in Nigeria. It will test how well a daily pill called hydroxyurea works in 220 children aged 5-12 who are at high risk for stroke. The goal is to see if this affordable and practical treatment can safely and effectively protect these children from having a stroke.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aminu Kano Teaching Hospital
RECRUITINGKano, Nigeria
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Murtala Muhammad Specialist Hospital
RECRUITINGKano, Nigeria
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.